Alternatives to Reyia

Digital pathology imaging technology and AI-driven precision pathology software.

Leveraging the adaptive immune system to diagnose and treat disease.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

EarlySense provides a continuous patient monitoring solution to enhance safety and reduce risk for general care patients.

AI-powered spatial biology platform for precision medicine and drug development.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.

Intelligent clinical surveillance platform for proactive patient care and optimized hospital interventions.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Developing engineered biologics to harness the immune system for disease treatment.

Comprehensive whole-genome monitoring for cancer recurrence and progression.

Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

AI-driven diagnostics company predicting cancer treatment response from pathology slides.

MeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes.

Lunit is a medical AI company developing AI-powered solutions for cancer diagnostics and therapeutics.

Leveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.

Personalized nutrition and metabolic health platform using gut microbiome and AI.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.